Purple Biotech Ltd. (PPBT)
1.64
-0.01
(-0.61%)
USD |
NASDAQ |
Aug 26, 11:48
Purple Biotech Enterprise Value : -3.359M for Aug. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 25, 2026 | -3.359M |
| August 24, 2026 | -3.504M |
| August 21, 2026 | -3.488M |
| August 20, 2026 | -3.472M |
| August 19, 2026 | -3.456M |
| August 18, 2026 | -3.504M |
| August 17, 2026 | -3.553M |
| August 14, 2026 | -3.602M |
| August 13, 2026 | -3.610M |
| August 12, 2026 | -3.634M |
| August 11, 2026 | -3.521M |
| August 10, 2026 | -3.602M |
| August 07, 2026 | -3.715M |
| August 06, 2026 | -3.747M |
| August 05, 2026 | -3.602M |
| August 04, 2026 | -3.602M |
| August 03, 2026 | -3.650M |
| July 31, 2026 | -3.763M |
| July 30, 2026 | -3.812M |
| July 29, 2026 | -3.796M |
| July 28, 2026 | -3.812M |
| July 27, 2026 | -3.699M |
| July 24, 2026 | -3.715M |
| July 23, 2026 | -3.780M |
| July 22, 2026 | -3.877M |
| Date | Value |
|---|---|
| July 21, 2026 | -3.780M |
| July 20, 2026 | -3.682M |
| July 17, 2026 | -3.650M |
| July 16, 2026 | -3.650M |
| July 15, 2026 | -3.715M |
| July 14, 2026 | -3.747M |
| July 13, 2026 | -3.569M |
| July 10, 2026 | -3.512M |
| July 09, 2026 | -3.375M |
| July 08, 2026 | -3.472M |
| July 07, 2026 | -3.456M |
| July 06, 2026 | -3.229M |
| July 02, 2026 | -3.278M |
| July 01, 2026 | -3.197M |
| June 30, 2026 | -3.310M |
| June 29, 2026 | -4.683M |
| June 26, 2026 | -4.739M |
| June 25, 2026 | -4.674M |
| June 24, 2026 | -4.674M |
| June 23, 2026 | -4.655M |
| June 22, 2026 | -4.720M |
| June 18, 2026 | -4.720M |
| June 17, 2026 | -4.665M |
| June 16, 2026 | -4.776M |
| June 15, 2026 | -4.730M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Teva Pharmaceutical Industries Ltd. | 57.61B |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 141.64M |
| Sol-Gel Technologies Ltd. | 220.39M |
| PolyPid Ltd. | 98.39M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.4486M |
| Total Expenses (Quarterly) | -0.4486M |
| EPS Diluted (Quarterly) | 0.4069 |
| Earnings Yield | -1.71K% |
| Normalized Earnings Yield | -856.74 |